Xiaokai Yan

1.2k total citations · 1 hit paper
16 papers, 739 citations indexed

About

Xiaokai Yan is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaokai Yan has authored 16 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaokai Yan's work include Ferroptosis and cancer prognosis (4 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Xiaokai Yan is often cited by papers focused on Ferroptosis and cancer prognosis (4 papers), RNA modifications and cancer (4 papers) and Cancer-related molecular mechanisms research (4 papers). Xiaokai Yan collaborates with scholars based in China, Australia and United States. Xiaokai Yan's co-authors include Kefei Yuan, Hong Wu, Xiangyong Hao, Jiwei Huang, Lin Xu, Yong Zeng, Haotian Liao, Mingheng Liao, Xi Chen and Jiaxin Li and has published in prestigious journals such as Cancer Research, Scientific Reports and Molecular Cancer.

In The Last Decade

Xiaokai Yan

16 papers receiving 734 citations

Hit Papers

KIAA1429 contributes to liver cancer progression through ... 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3
    2019 349 citations Tian Lan, Hui Li et al. Molecular Cancer profile →

Peers

Xiaokai Yan
Hua Dong China
Paul A. Algate United States
Hanne Hella Norway
Michelle Blake United States
Petranel T. Ferrão Australia
C. Ormazábal Spain
Mitsuharu Hirai Japan
Yvonne de Jong Netherlands
Kenneth A. Bøtkjær Denmark
Hua Dong China
Xiaokai Yan
Citations per year, relative to Xiaokai Yan Xiaokai Yan (= 1×) peers Hua Dong

Countries citing papers authored by Xiaokai Yan

Since Specialization
Citations

This map shows the geographic impact of Xiaokai Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaokai Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaokai Yan more than expected).

Fields of papers citing papers by Xiaokai Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaokai Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaokai Yan. The network helps show where Xiaokai Yan may publish in the future.

Co-authorship network of co-authors of Xiaokai Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaokai Yan. A scholar is included among the top collaborators of Xiaokai Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaokai Yan. Xiaokai Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Yan, Xiaokai, et al.. (2024). DNMT3L inhibits hepatocellular carcinoma progression through DNA methylation of CDO1: insights from big data to basic research. Journal of Translational Medicine. 22(1). 128–128. 3 indexed citations
2.
Yan, Xiaokai, Xinyue Yao, Lulu Yin, et al.. (2024). N6-methyladenosine regulators in hepatocellular carcinoma: investigating the precise definition and clinical applications of biomarkers. Biology Direct. 19(1). 103–103. 1 indexed citations
3.
Zhang, Yi, Hongquan Yu, Yunqian Li, et al.. (2023). Raman spectroscopy: A prospective intraoperative visualization technique for gliomas. Frontiers in Oncology. 12. 1086643–1086643. 11 indexed citations
4.
Chen, Xing, Liangqing Dong, Lu Chen, et al.. (2022). Epigenome-wide development and validation of a prognostic methylation score in intrahepatic cholangiocarcinoma based on machine learning strategies. HepatoBiliary Surgery and Nutrition. 12(4). 478–494. 1 indexed citations
5.
Liu, Xiao, et al.. (2022). Identification of multi-omics biomarkers and construction of the novel prognostic model for hepatocellular carcinoma. Scientific Reports. 12(1). 12084–12084. 9 indexed citations
6.
Yan, Xiaokai, et al.. (2021). Effect of unfolded protein response on the immune infiltration and prognosis of transitional cell bladder cancer. Annals of Medicine. 53(1). 1049–1059. 6 indexed citations
7.
Lan, Tian, Hui Li, Lin Xu, et al.. (2019). KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3. Molecular Cancer. 18(1). 186–186. 349 indexed citations breakdown →
8.
Liao, Haotian, Mingheng Liao, Lin Xu, et al.. (2019). Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinoma. EBioMedicine. 41. 310–319. 6 indexed citations
9.
Lan, Tian, Kefei Yuan, Xiaokai Yan, et al.. (2019). LncRNA SNHG10 Facilitates Hepatocarcinogenesis and Metastasis by Modulating Its Homolog SCARNA13 via a Positive Feedback Loop. Cancer Research. 79(13). 3220–3234. 99 indexed citations
10.
Xu, Liangliang, Yanfang Zhang, Peng Wang, et al.. (2019). The Prognostic Value and Regulatory Mechanisms of microRNA-145 in Various Tumors: A Systematic Review and Meta-analysis of 50 Studies. Cancer Epidemiology Biomarkers & Prevention. 28(5). 867–881. 26 indexed citations
11.
Yan, Xiaokai, Haifeng Wan, Xiangyong Hao, et al.. (2018). Importance of gene expression signatures in pancreatic cancer prognosis and the establishment of a prediction model. Cancer Management and Research. Volume 11. 273–283. 40 indexed citations
12.
Tan, Ping, et al.. (2017). Sofosbuvir in combination with daclatasvir in liver transplant recipients with HCV infection: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology. 41(3). 262–271. 11 indexed citations
13.
Yan, Xiaokai, et al.. (2014). Epiphyseal Separation of Distal Humerus in Newborn: A Case Report. 22–25. 1 indexed citations
14.
Rahgozar, Soheila, Bill Giannakopoulos, Xiaokai Yan, et al.. (2008). Beta2‐glycoprotein I protects thrombin from inhibition by heparin cofactor II: Potentiation of this effect in the presence of anti–β2‐glycoprotein I autoantibodies. Arthritis & Rheumatism. 58(4). 1146–1155. 19 indexed citations
15.
16.
Shi, Tong, Bill Giannakopoulos, Xiaokai Yan, et al.. (2006). Anti–β2‐glycoprotein I antibodies in complex with β2‐glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib‐IX‐V. Arthritis & Rheumatism. 54(8). 2558–2567. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hua Dong Breakdown of academic impact, for papers by Paul A. Algate Breakdown of academic impact, for papers by Hanne Hella Breakdown of academic impact, for papers by Michelle Blake Breakdown of academic impact, for papers by Petranel T. Ferrão Breakdown of academic impact, for papers by C. Ormazábal Breakdown of academic impact, for papers by Mitsuharu Hirai Breakdown of academic impact, for papers by Yvonne de Jong Breakdown of academic impact, for papers by Kenneth A. Bøtkjær
Rankless by CCL
2026